Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05097521 · ClinicalTrials.gov registry record

Assessing Pain, Patient Reported Outcomes and Complementary and Integrative Health

A clinical trial of Chronic Musculoskeletal Pain, sponsored by VA Office of Research and Development.

Completed
Registry status
3,726
Enrollment target
2
Study locations

NCT05097521: Completed study of Chronic Musculoskeletal Pain, sponsored by VA Office of Research and Development.

NCT05097521 is a study of Chronic Musculoskeletal Pain that has completed, run by VA Office of Research and Development. The registered enrollment target is 3,726 participants, above the 149-participant average among 13 other Chronic Musculoskeletal Pain trials with a reported enrollment target (2401% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05097521, a study of Chronic Musculoskeletal Pain, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
3,726 participants
Enrollment target
2
Study locations

Study Summary

The APPROACH Study (Assessing Pain, Patient-Reported Outcomes and Complementary and Integrative Health) assesses the effects of use of practitioner-delivered CIH therapies alone compared to the combination of self-care and practitioner-delivered CIH therapies among Veterans with chronic musculoskeletal pain. The APPROACH study is predominately conducting a secondary analysis of patient-reported data being collected by the Veterans Health Administration's (VA) Office of Patient Centered Care and Cultural Transformation among Veterans using 18 VA medical centers. Those facilities received funding as part of the Comprehensive Addiction and Recovery Act to expand availability of CIH therapies. That patient-reported data is being supplemented with VA electronic health record data and data on the 18 medical centers' business practices (nudges, the instrumental variable). Practitioner-delivered therapies under study include chiropractic care, acupuncture and therapeutic massage, and self-care therapies include Tai Chi/qigong, yoga and meditation. The primary outcomes are improvement in pain severity and pain interference, using the Brief Pain Inventory (BPI), 6 months after initiating CIH therapies compared to baseline. Patients will enter treatment groups based on the CIH therapies they use, as randomizing patients to specific therapies would require withholding therapies routinely offered at VA. The investigators will address selection bias and confounding by using sites' variations in business practices and other encouragements (nudges) to receiving different CIH therapies as a surrogate for direct randomization using instrumental variables econometric methods.

Primary Outcome

Measure of pain severity. Scores range from 0-10, with higher scores indicating more severe pain.

Interventions

  • OTHER Practitioner-delivered CIH therapies (acupuncture, therapeutic massage, chiropractic care) as received in VHA and community practice settings
  • OTHER Self-care CIH therapies (yoga, Tai Chi/Qigong , meditation) as received in VHA and community practice settings
  • OTHER Combination of practitioner-delivered and self-care CIH therapies (described above) as received in VHA and community practice settings

Study Locations (2)

California

  • VA Greater Los Angeles Healthcare System, Sepulveda, CA - Sepulveda

Washington

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle

Trial Details

FieldValue
Enrollment Target 3,726 participants
Start Date 2021-03-17
Est. Completion 2023-09-17
VA Office of Research and Development

1,668 total trials

What the finished NCT05097521 record still lists

NCT05097521 is an observational study that tracks outcomes without assigning an intervention. Its 3,726 participants enrollment target places it among the larger protocols in the corpus, above the 149-participant average among 13 other Chronic Musculoskeletal Pain trials with a reported enrollment target (2401% higher).

The record links to 1 condition, with Chronic Musculoskeletal Pain appearing as the primary indexed condition, and to 3 interventions - of which Practitioner-delivered CIH therapies (acupuncture, therapeutic massage, chiropractic care) as received in VHA and community practice settings is the first listed.

NCT05097521 reports a single indexed study location in California, Washington.

Frequently Asked Questions

What is clinical trial NCT05097521 about?

NCT05097521 is a clinical study titled "Assessing Pain, Patient Reported Outcomes and Complementary and Integrative Health". The APPROACH Study (Assessing Pain, Patient-Reported Outcomes and Complementary and Integrative Health) assesses the effects of use of practitioner-delivered CIH therapies alone compared to the combination of self-care and practitioner-delivered CIH therapies among Veterans with chronic musculoskele...

What is the current status of trial NCT05097521?

This trial is currently completed. The enrollment target is 3,726 participants. The study started on 2021-03-17. Estimated completion is 2023-09-17.

What conditions does trial NCT05097521 study?

This clinical trial studies the following conditions: Chronic Musculoskeletal Pain.

What interventions are being tested in trial NCT05097521?

The interventions under investigation include: Practitioner-delivered CIH therapies (acupuncture, therapeutic massage, chiropractic care) as received in VHA and community practice settings (OTHER), Self-care CIH therapies (yoga, Tai Chi/Qigong , meditation) as received in VHA and community practice settings (OTHER), Combination of practitioner-delivered and self-care CIH therapies (described above) as received in VHA and community practice settings (OTHER).

Who is sponsoring clinical trial NCT05097521?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05097521 being conducted?

This trial has 2 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Musculoskeletal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05097521's enrollment target sits among peer trials

3,726 1st of 13 higher than 13 of 13 other Chronic Musculoskeletal Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Musculoskeletal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06076304 · 3,720 participants · Phase 4

    Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis

  • NCT06172660 · 3,750 participants

    Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

  • NCT06298253 · 3,750 participants · NA

    Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2

  • NCT06401863 · 3,691 participants · NA

    Shared Decision for Drug Interactions in Oral Anticoagulation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05097521, the US trial registry maintained by the National Library of Medicine. NCT05097521 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.